Entering text into the input field will update the search result below

XCUR Exicure, Inc.
Stock Price & Overview

$0.750.0079 (+1.06%)1:31 PM 10/03/23
NASDAQ | $USD | Delayed

Charts

FFO (FWD)
PE
Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Company Profile

Exicure, Inc. logo
Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company’s preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Employees
7
Founded
2011
Address
  • 2430 North Halsted Street
  • Chicago, IL, 60614
  • United States
Phone Number
847 673 1700
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.